Filing Details

Accession Number:
0001601364-15-000002
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2015-01-26 17:31:29
Reporting Period:
2015-01-22
Filing Date:
2015-01-26
Accepted Time:
2015-01-26 17:31:29
Original Submission Date:
2015-01-26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1513818 Versartis Inc. VSAR Pharmaceutical Preparations (2834) 244106690
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1601363 Advent Life Sciences Fund I Lp 158 North Gower Street
London X0 NW1 2ND
No No No Yes
1601364 Llp Sciences Life Advent 158 North Gower Street
London X0 NW1 2ND
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-22 55,000 $17.25 2,271,558 No 4 P Indirect See FN
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See FN
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Option (Right to Buy) $21.00 2024-03-19 35,000 35,000 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-03-19 35,000 35,000 Indirect
Footnotes
  1. Securities are held by Advent Life Sciences LLP ("Advent") and Advent Life Sciences Fund I LP ("Advent Fund"). Advent is the general partner of Advent Fund. Advent disclaims beneficial ownership of the shares held by Advent Fund except to the extent of its indirect pecuniary interest therein. Shahzad Malik, an affiliate of the Reporting Persons, is a member of the Issuer's board of directors, and disclaims beneficial ownership of the shares held by Advent or the Advent Fund except to the extent of his indirect pecuniary interest therein.
  2. One-fourth of the total number of shares subject to the option shall vest and become exercisable one year from 3/21/2014 (the "Vesting Commencement Date") and 1/36th of the remaining number of shares subject to the option shall vest and become exercisable on each monthly anniversary of the Vesting Commencement Date thereafter.
  3. Securities are held by Shahzad Malik, an affiliate of the Reporting Persons. The Reporting Persons disclaim beneficial ownership of the securities held by Shahzad Malik.